Trials / Completed
CompletedNCT05735886
Urolithin A Supplementation to Boost Immune Health
Impact of Urolithin A Supplementation on Mitochondrial Health of Immune Cells (MitoImmune): a Randomized Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Amazentis SA · Industry
- Sex
- All
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To show that a natural mitophagy activator (Urolithin A) given orally can modulate mitochondrial activity in immune cells in healthy adults and this results in better immune function
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Softgel containing placebo | Single oral dose administration (4 softgels) to be orally administered daily according to the randomization for 28 days |
| DIETARY_SUPPLEMENT | Softgel containing 250mg of Urolithin A (Mitopure) | Single oral dose administration (4 softgels) to be orally administered daily according to the randomization for 28 days |
Timeline
- Start date
- 2023-01-30
- Primary completion
- 2024-03-31
- Completion
- 2024-08-31
- First posted
- 2023-02-21
- Last updated
- 2024-09-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05735886. Inclusion in this directory is not an endorsement.